Quick identification and testing of blood infections using whole blood samples
Rapid ID and AST Directly from Whole Blood Using Single Molecule Detection
['FUNDING_R01'] · SCANOGEN, INC. · NIH-11040347
This study is working on a fast test that can quickly find infections in your blood and check which antibiotics will work best, helping doctors treat you more effectively and sooner.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SCANOGEN, INC. (nih funded) |
| Locations | 1 site (Baltimore, UNITED STATES) |
| Trial ID | NIH-11040347 on ClinicalTrials.gov |
What this research studies
This research aims to develop a rapid diagnostic platform that can identify bloodstream infections and test for antibiotic susceptibility directly from whole blood samples. By utilizing a novel technique called Single MOlecule Tethering (SMOLT), the platform is designed to provide results within hours instead of days, allowing for timely and targeted treatment. The approach focuses on detecting bacteria and determining their resistance to antibiotics quickly, which is crucial for effective patient care. If successful, this method could significantly improve the management of infections caused by resistant organisms.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients experiencing bloodstream infections, particularly those at risk of antibiotic-resistant infections.
Not a fit: Patients who do not have bloodstream infections or those whose infections are not caused by bacteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective treatment options for patients with bloodstream infections.
How similar studies have performed: Other research has shown promise in rapid diagnostic techniques for infections, suggesting that this approach could be a significant advancement in the field.
Where this research is happening
Baltimore, UNITED STATES
- SCANOGEN, INC. — Baltimore, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CELEDON, ALFREDO ANDRES — SCANOGEN, INC.
- Study coordinator: CELEDON, ALFREDO ANDRES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.